FORMES SOLIDES AMORPHES DU CHLORHYDRATE DE LA 4-[-2-[[5-MÉTHYL-1-(2-NAPHTALÉNYL)-1H-PYRAZOL-3-YL]OXY]ÉTHYL]MORPHOLINE
LA PRÉSENTE INVENTION CONCERNE DES FORMES SOLIDES PRÉSENTANT UN FAIBLE DEGRÉ DE CRISTALLINITÉ OU PRATIQUEMENT AMORPHES DU SEL DE CHLORHYDRATE DE LA 4-[2-[[5-MÉTHYL-1-(2-NAPHTALÉNYL)-1H-PYRAZOL-3-YL]OXY]ÉTHYL]MORPHOLINE (P027) ET DES PROCÉDÉS POUR LEUR PRÉPARATION. The present invention relates to so...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PUIG FERNANDEZ, LAURA BENET BUCHHOLZ, JORDI |
| description | LA PRÉSENTE INVENTION CONCERNE DES FORMES SOLIDES PRÉSENTANT UN FAIBLE DEGRÉ DE CRISTALLINITÉ OU PRATIQUEMENT AMORPHES DU SEL DE CHLORHYDRATE DE LA 4-[2-[[5-MÉTHYL-1-(2-NAPHTALÉNYL)-1H-PYRAZOL-3-YL]OXY]ÉTHYL]MORPHOLINE (P027) ET DES PROCÉDÉS POUR LEUR PRÉPARATION.
The present invention relates to solid forms having a low degree of crystallinity or substantially amorphous of the hydrochloride salt of 4-[2-[[5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine (P027) and processes for their preparation. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MA34512B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MA34512B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MA34512B13</originalsourceid><addsrcrecordid>eNrjZKhw8w_ydQ1WCPb38XQB0o6-_kEBHkCGS6iCs4ePf5BHpEuQY4irgourgo-jgolutK6RbnS0qa7v4c4Qj0gfXUNdDSNdP8cAjxBHn8OdfpE-mrqGHroBkUGOUf4-usa6kT6x_hGRsRDVsWDTgVb5ufIwsKYl5hSn8kJpbgY5N9cQZw_d1IL8-NTigsTk1LzUknhfR2MTU0MjJ0NjggoAPVo6_g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FORMES SOLIDES AMORPHES DU CHLORHYDRATE DE LA 4-[-2-[[5-MÉTHYL-1-(2-NAPHTALÉNYL)-1H-PYRAZOL-3-YL]OXY]ÉTHYL]MORPHOLINE</title><source>esp@cenet</source><creator>PUIG FERNANDEZ, LAURA ; BENET BUCHHOLZ, JORDI</creator><creatorcontrib>PUIG FERNANDEZ, LAURA ; BENET BUCHHOLZ, JORDI</creatorcontrib><description>LA PRÉSENTE INVENTION CONCERNE DES FORMES SOLIDES PRÉSENTANT UN FAIBLE DEGRÉ DE CRISTALLINITÉ OU PRATIQUEMENT AMORPHES DU SEL DE CHLORHYDRATE DE LA 4-[2-[[5-MÉTHYL-1-(2-NAPHTALÉNYL)-1H-PYRAZOL-3-YL]OXY]ÉTHYL]MORPHOLINE (P027) ET DES PROCÉDÉS POUR LEUR PRÉPARATION.
The present invention relates to solid forms having a low degree of crystallinity or substantially amorphous of the hydrochloride salt of 4-[2-[[5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine (P027) and processes for their preparation.</description><language>fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130902&DB=EPODOC&CC=MA&NR=34512B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130902&DB=EPODOC&CC=MA&NR=34512B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PUIG FERNANDEZ, LAURA</creatorcontrib><creatorcontrib>BENET BUCHHOLZ, JORDI</creatorcontrib><title>FORMES SOLIDES AMORPHES DU CHLORHYDRATE DE LA 4-[-2-[[5-MÉTHYL-1-(2-NAPHTALÉNYL)-1H-PYRAZOL-3-YL]OXY]ÉTHYL]MORPHOLINE</title><description>LA PRÉSENTE INVENTION CONCERNE DES FORMES SOLIDES PRÉSENTANT UN FAIBLE DEGRÉ DE CRISTALLINITÉ OU PRATIQUEMENT AMORPHES DU SEL DE CHLORHYDRATE DE LA 4-[2-[[5-MÉTHYL-1-(2-NAPHTALÉNYL)-1H-PYRAZOL-3-YL]OXY]ÉTHYL]MORPHOLINE (P027) ET DES PROCÉDÉS POUR LEUR PRÉPARATION.
The present invention relates to solid forms having a low degree of crystallinity or substantially amorphous of the hydrochloride salt of 4-[2-[[5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine (P027) and processes for their preparation.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZKhw8w_ydQ1WCPb38XQB0o6-_kEBHkCGS6iCs4ePf5BHpEuQY4irgourgo-jgolutK6RbnS0qa7v4c4Qj0gfXUNdDSNdP8cAjxBHn8OdfpE-mrqGHroBkUGOUf4-usa6kT6x_hGRsRDVsWDTgVb5ufIwsKYl5hSn8kJpbgY5N9cQZw_d1IL8-NTigsTk1LzUknhfR2MTU0MjJ0NjggoAPVo6_g</recordid><startdate>20130902</startdate><enddate>20130902</enddate><creator>PUIG FERNANDEZ, LAURA</creator><creator>BENET BUCHHOLZ, JORDI</creator><scope>EVB</scope></search><sort><creationdate>20130902</creationdate><title>FORMES SOLIDES AMORPHES DU CHLORHYDRATE DE LA 4-[-2-[[5-MÉTHYL-1-(2-NAPHTALÉNYL)-1H-PYRAZOL-3-YL]OXY]ÉTHYL]MORPHOLINE</title><author>PUIG FERNANDEZ, LAURA ; BENET BUCHHOLZ, JORDI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MA34512B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>fre</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PUIG FERNANDEZ, LAURA</creatorcontrib><creatorcontrib>BENET BUCHHOLZ, JORDI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PUIG FERNANDEZ, LAURA</au><au>BENET BUCHHOLZ, JORDI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FORMES SOLIDES AMORPHES DU CHLORHYDRATE DE LA 4-[-2-[[5-MÉTHYL-1-(2-NAPHTALÉNYL)-1H-PYRAZOL-3-YL]OXY]ÉTHYL]MORPHOLINE</title><date>2013-09-02</date><risdate>2013</risdate><abstract>LA PRÉSENTE INVENTION CONCERNE DES FORMES SOLIDES PRÉSENTANT UN FAIBLE DEGRÉ DE CRISTALLINITÉ OU PRATIQUEMENT AMORPHES DU SEL DE CHLORHYDRATE DE LA 4-[2-[[5-MÉTHYL-1-(2-NAPHTALÉNYL)-1H-PYRAZOL-3-YL]OXY]ÉTHYL]MORPHOLINE (P027) ET DES PROCÉDÉS POUR LEUR PRÉPARATION.
The present invention relates to solid forms having a low degree of crystallinity or substantially amorphous of the hydrochloride salt of 4-[2-[[5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine (P027) and processes for their preparation.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | fre |
| recordid | cdi_epo_espacenet_MA34512B1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | FORMES SOLIDES AMORPHES DU CHLORHYDRATE DE LA 4-[-2-[[5-MÉTHYL-1-(2-NAPHTALÉNYL)-1H-PYRAZOL-3-YL]OXY]ÉTHYL]MORPHOLINE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T18%3A55%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PUIG%20FERNANDEZ,%20LAURA&rft.date=2013-09-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMA34512B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |